Vectorious Medical Technologies
Tel Aviv, Israel· Est.
Implantable left‑atrial pressure sensor platform for chronic heart‑failure management.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Implantable left‑atrial pressure sensor platform for chronic heart‑failure management.
CardiologyHeart Failure
Technology Platform
Implantable MEMS sensor measuring left atrial pressure with wireless power harvesting and cloud‑based analytics for real‑time cardiac monitoring.
Opportunities
Scaling the V‑LAP platform to broader cardiac and chronic disease indications, and leveraging its data‑analytics engine for personalized therapy management.
Risk Factors
Regulatory approval uncertainties, need for robust clinical validation, and competition from established remote cardiac monitoring devices.
Competitive Landscape
Competes with Medtronic CardioMEMS and Abbott HeartLogic; differentiation lies in direct left‑atrial pressure measurement, battery‑free operation, and a cloud‑native analytics platform.